Table 1

Characteristics of study participants, study characteristics and risk of bias assessment of included studies

Author, year
Country (reference)
Participants n, age,
(female%)*
Type of injury and (intervention)†Activity level‡OA classification
(radiographic/self-reported/
clinical)
Comparison
(n and type)§
Years of follow-up
(mean, SD/range)
Risk of bias assessment
(Total and ratio score)¶
Ait Si Selmi, 2006
France21
n=89,
22.0 (11%)
Combined
(ACL reconstr.)
Not reportedIKDCn=89
Opposite knee
17.4+ (8/13)
Andersson-Molina, 2002
Sweden22
n=36,
29.0, (0%)
Meniscus
(APM - medial)
1Ahlbäckn=18
Matched controls
14.0+ (11/13) retrospective
n=36,
28.0, (0%)
Menisc
(total meniscect.)
1Ahlbäckn=18
Matched controls
14.0+ (11/13)
Barenius, 2014
Sweden23
n=69,
24.0, (49%)
Combined
(ACL reconstr. BTPB)
0KLn=69
Opposite knee
15.2++ (10/13)
n=65,
26.1, (32%)
Combined
(ACL reconstr.)
0KLn=65
Opposite knee
15.5++ (10/13)
Bonneaux, 2002
Belgium24
n=29,
25.0, (31%)
Meniscus
(APM lateral)
1Fairbankn=29
Opposite knee
8.0 (SD 1.5)+ (7/13)
Bulgheroni, 2015
Italy25
n=34,
31.0, (76%)
Combined
(ACL reconstr. – meniscect./CMI impl.)
0KLn=34
Opposite knee
11.8 (SD 2.4)+ (5/13)
Chatain, 2001
France26
n=218,
38.0, (19%)
Menisc
(medial meniscect.)
1IKDCn=218
Opposite knee
11.5 (10–15)+ (6/13)
Chatain, 2003
France27
n=64,
35.0, (18%)
Meniscus
(lateral meniscect.)
1IKDCn=64
Opposite knee
11.0 (SD 1.4)+ (6/13)
Chen, 2017
China28
n=59,
28.6, (14%)
Combined
(ACL reconstr.-ham.)
1KLn=59
Opposite knee
11.7 (SD 1.0)+ (9/13)
n=30,
27.6, (36%)
Combined
ACL reconstr.-syn.)
1KLn=30
Opposite knee
11.6 (SD 2.3)+ (9/13)
Englund, 2009
USA17
n=405,
61.6, (62%)
Meniscus tear
(no intervention)
0KLn=294
Matched controls
2.5+ (12/13) retrospective
Faunø, 1992
Denmark29
n=136,
33.8, (26%)
Meniscus
(arthroscop. resec.)
0Fairbankn=136
Opposite knee
8.5 (8–12)+ (7/13)
Golightly, 2009
USA30
n=2511,
53.8 follow-up, (0%)
ACL
(not reported)
1Self-reportedn=1390
Matched controls
More than 10 years- (3/13)
n=2511,
53.8 follow-up, (0%)
Meniscus
(not reported)
1Self-reportedn=1315
Matched controls
More than 10 years- (3/13)
Hart, 2005
UK31
n=16,
27.8, (32%)
Combined
(PBTB +meniscect.)
0Ahlbäckn=16
Opposite knee
10 (9–13)+ (6/13)
n=15,
27.8, (32%)
ACL
(PBTB reconstruct.)
0Ahlbäckn=15
Opposite knee
10 (9–13)+ (6/13)
Hoffelner, 2012
Austria32
n=28,
22.4, (25%)
ACL
(PBTB/hamstring)
1KLn=28
Opposite knee
10.0+ (6/13)
Hulet, 2015
France33
n=89,
35.0 (37%)
Meniscus
(APM lateral)
0IKDCn=89
Opposite knee
22.0 (SD 3.0)+ (9/13)
Inderhaug, 2013
Norway34
n=78,
28.0, (34%)
Combined
(ACL autograft)
1IKDCn=78
Opposite knee
11.0 (SD 0.6)+ (6/13)
Jackson, 1968
UK35
n=382,
35.8, (11%)
Meniscus
(meniscect.)
Not reportedother (radiographic)n=382
Opposite knee
11.0+ (5/13)
Jarvela, 2017
Finland36
n=24,
34.0, (30%)
Combined
(ACL – DB auto.)
Not reportedKLn=24
Opposite knee
13.1 (SD 0.3)+ (8/13)
n=23,
30.0, (30%)
Combined
(ACL – SB bio.)
Not reportedKLn=23
Opposite knee
13.1 (SD 0.3)+ (8/13)
n=23,
33.0, (37%)
Combined
(ACL – SB metal.)
Not reportedKLn=23
Opposite knee
13.1 (SD 0.3)+ (8/13)
Jauregito, 1995
USA37
n=18,
30.0, (not reported)
Meniscus
(part. lat. menisect.)
Not reportedFairbankn=18
Opposite knee
8.0 (6–11)+ (6/13)
Johnson, 1999
USA38
n=34,
18.9, (11%)
Meniscus
(meniscal repair)
Not reportedFairbankn=34
Opposite knee
10.9 (8–13)+ (7/13)
Johnson, 2015
USA39
n=710,
56.0, (67%)
ACL
(not reported)
0KLn=355
Matched controls
4+ (5/13)
Karikis, 2018
Sweden40
n=29,
26.0, (50%)
Combined
(ACL reconstr. early)
1KLn=29
Opposite knee
10.5 (SD 2.6)+ (8/13)
n=29,
27.0, (39%)
Combined
(ACL reconstr. late)
1KLn=29
Opposite knee
13.3 (SD 2.7)+ (8/13)
Khan, 2018
UK41
n=154 076,
57.3, (27%)
Combined
(TKA)
Not reportedClinicaln=104 353
Matched controls
More than 20 years++ (11/13)
n=154 076,
65.1, (37%)
Meniscus
(TKA)
Not reportedClinicaln=104 353
Matched controls
More than 20 years++ (11/13)
Leiter, 2014
Canada42
n=68,
31,2, (37%)
ACL
(autograft)
1KLn=68
Opposite knee
14.6 (SD 1.9)+ (7/13)
Leroux, 2014
Canada43
n=181 451,
28.0, (35%)
ACL
(TKA)
Not reportedClinicaln=151 362
Matched controls
15+ (10/13) retrospective
Li, 2011
USA44
n=249,
26.4, (39%)
ACL
(single bundle)
1KLn=249
Opposite knee
9.5 (4–22)+ (8/13)
Lohmander, 2004
Sweden45
n=41,
19.0, (100%)
Combined
(ACL reconstr.)
1KLn=41
Opposite knee
12+ (8/13)
n=26,
19.0, (100%)
Combined
(no surgery)
1KLn=26
Opposite knee
12+ (8/13)
Majewski, 2006
Switzerland46
n=64,
29.8, (39%)
Meniscus
(suture repair)
1Fairbankn=64
Opposite knee
10.0 (5–17)+ (9/13)
Maletius, 1997
Sweden47
n=52,
25.4, (34%)
Combined
(ACL reconstruct.)
0Ahlbäckn=52
Opposite knee
9.0 (7–11)+ (7/13)
Maletius, 1996
Sweden48
n=21,
28.0, (24%)
Meniscus
(APM)
0Ahlbäckn=21
Opposite knee
13.0 (12–15)+ (9/13)
Meuffels, 2009
Netherlands49
n=50,
27.7, (24%)
Combined
(BPTB reconstruct.)
1KLn=50
Opposite knee
10.0+ (6/13)
Meunier, 2007
Sweden50
n=93,
22.0, (32%)
Combined
(ACL repair)
Not reportedAhlbäckn=93
Opposite knee
15.0 (14–19)+ (7/13)
Murray, 2004
UK51
n=18,
28.4, (6%)
ACL
(allograft)
0IKDCn=18
Opposite knee
13.0 (11–16)+ (5/13)
Murray, 2012
Australia52
n=84,
30.0, (not reported)
Combined
(ACL autograft)
1IKDCn=84
Opposite knee
13.0+ (7/13)
n=29,
30.0, (not reported)
ACL
(autograft)
1IKDCn=29
Opposite knee
13.0+ (7/13)
Neyret, 1993
France53
n=92,
32.5, (22%)
Meniscus
(partial meniscect.)
0Other (radiographic)n=92
Opposite knee
26.0 (20–34)+ (6/13)
n=88,
24.0, (22%)
Combined
(partial meniscect.)
1Other (radiographic)n=88
Opposite knee
27.0 (20–34)+ (6/13)
Oiestad, 2011
Norway54
n=210,
25.4, (43%)
Combined
(ACL autograft)
Not reportedKLn=210
Opposite knee
13.7 (SD 4.4)++ (10/13)
Persson, 2018
Sweden55
n=645 967,
30.5, (26%)
Combined
(Repair/part. menisc.)
Not reportedClinicaln=643 480
Matched controls
10.5 (median, range 5–18)++10/13)
Reid, 1992
USA56
n=32,
22.0, (16%)
Combined
(ACL reconstruc.)
1other (radiographic)n=32
Opposite knee
11.0 (7–15)+ (7/13)
Rockborn, 1995
Sweden57
n=33,
19.0, (14%)
Meniscus
(meniscect.)
1Ahlbäckn=33
Opposite knee
13.0 (11–15)+ (6/13)
Rockborn, 2000
Sweden58
n=62,
25.0, (16%)
Meniscus
(open meniscect.)
1Ahlbäckn=31
Matched controls
13.5 (11–19)+ (7/13)
Roos, 2008
Sweden59
n=291,
34.4, (19%)
Meniscus
(isolated menicect.)
Not reportedKLn=50
Matched controls
18.2 (SD 2.3)+ (10/13) retrospective
Sanders, 2017
USA60
n=728,
31.5, (40%)
Combined
(none)
Not reportedClinicaln=364
Matched controls
14.3 (SD 7.4)+ (7/13)
Scheller, 2001
Germany61
n=23,
39.9, (42%)
Meniscus
(partial meniscect.)
Not reportedJäger-Wirthn=23
Opposite knee
12.3 (10–15)+ (7/13)
n=35,
42.5, (42%)
Meniscus
(partial meniscect.)
Not reportedJäger-Wirthn=35
Opposite knee
7.1 (5–9)+ (7/13)
Segawa, 2001
Japan62
n=70,
22.8, (40%)
Combined
(no surgery)
0KLn=70
Opposite knee
11.9 (5–27)+ (7/13)
Sommerlath, 1991
Sweden63
n=38,
28.0, (20%)
Combined
(ACL repair)
0Ahlbäckn=38
Opposite knee
12.0 (9–16)+ (6/13)
Sonne Holm, 1980
Denmark64
n=131,
25.0, (14%)
Meniscus
(total menicectomy)
1Ahlbäckn=131
Opposite knee
4.25 (median, range 2.3–11)+ (9/13)
Stein, 2010
Germany65
n=26,
31.1, (38%)
Meniscus
(repair)
1Fairbankn=26
Opposite knee
9.0+ (9/13)
n=20,
30.4, (31%)
Meniscus
(partial meniscect.)
1Fairbankn=20
Opposite knee
9.0+ (9/13)
Strand, 2005
Norway66
n=61,
28.0, (not reported)
ACL
(open repair)
0IKDCn=61
Opposite knee
23.0+ (7/13)
Sun, 2009
China67
n=76,
29.8, (20%)
Combined
(BPTB autograft)
0KLn=76
Opposite knee
5.6+ (6/13)
n=80,
30.7, (21%)
Combined
(BPTB allograft)
0KLn=80
Opposite knee
5.6+ (6/13)
Sun, 2011
China68
n=31,
28.5, (23%)
Combined
(hamstring allograft)
0KLn=31
Opposite knee
3.6+ (5/13)
n=38,
29.6, (18%)
Combined
(hamstring allograft)
0KLn=38
Opposite knee
3.6+ (5/13)
Sutherland, 2010
UK69
n=79,
31.0, (20%)
ACL
(reconstruc - BPLB)
0KLn=79
Opposite knee
11.0 (8–15)+ (8/13)
Thelin, 2006
Sweden18
n=631,
62.6 follow-up, (0%)
Meniscus0Ahlbäckn=293
Matched controls
More than 10 years+ (5/13)
n=842,
62.6 follow-up, (100%)
Meniscus0Ahlbäckn=402
Matched controls
More than 10 years+ (5/13)
van der Hart, 2008
Netherlands70
n=28,
27.6, (39%)
Combined
(ACL autograft)
0KLn=28
Opposite knee
10.3 (10–11)+ (7/13)
Yamaguchi, 2006
Japan71
n=24,
21.0, (31%)
Combined
(ACL reconstruc.)
1IKDCn=24
Opposite knee
24.0+ (7/13)
  • *n = number of participants included in analysis, age reported as mean years and gender as % females.

  • †ACL, meniscus, combined ACL and meniscus.

  • ‡Pre-operative Tegner score ≥7 = 1, <7 = 0.

  • §n = number of controls in analysis, type = opposite knee or matched controls.

  • ¶Total assessment score (++ high quality, + acceptable, - unacceptable), ratio score = number of items assessing bias in study/total number of items available for bias assessment.